Trial
NCT04303845
Erenumab For Treatment of Hemicrania Continua
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Mayo Clinic
Collaborators
—
Condition
Hemicrania Continua
Intervention
Erenumab
Why stopped
difficulty with recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-02-17